We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+6.08%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$42.8B
AUM Growth
+$3.35B
(+8.5%)
Cap. Flow
+$1.35B
Cap. Flow
% of AUM
3.15%
Top 10 Holdings %
Top 10 Hldgs %
14.82%
Holding
2,894
New
39
Increased
2,631
Reduced
168
Closed
44
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$21.8M |
| 2 |
Chevron
CVX
|
+$20.5M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$19.7M |
| 4 |
Incyte
INCY
|
+$17.8M |
| 5 |
ExxonMobil
XOM
|
+$16.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SE
Spectra Energy Corp Wi
SE
|
+$49.6M |
| 2 |
STJ
St Jude Medical
STJ
|
+$41.1M |
| 3 |
LLTC
Linear Technology Corp
LLTC
|
+$30.3M |
| 4 |
HAR
Harman International Industries
HAR
|
+$13.8M |
| 5 |
ENH
Endurance Specialty Holdings Ltd
ENH
|
+$10.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.2% |
| 2 | Technology | 15.06% |
| 3 | Healthcare | 13.05% |
| 4 | Industrials | 10.88% |
| 5 | Consumer Discretionary | 9.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2076
Globalstar
GSAT
$10.7B
| $729K | ﹤0.01% |
30,365
+3,284
| +12% | +$73.7K |
|
|
SYNT
2077
DELISTED
Syntel Inc
SYNT
| $729K | ﹤0.01% |
43,327
-306
| -0.7% | -$5.93K |
|
|
APFH
2078
DELISTED
AdvancePierre Foods Holdings
APFH
| $727K | ﹤0.01% |
23,329
+855
| +4% | +$24.7K |
|
|
ARAV
2079
DELISTED
Aravive, Inc. Common Stock
ARAV
| $725K | ﹤0.01% |
5,661
+270
| +5% | +$28.5K |
|
|
FLIC
2080
DELISTED
First of Long Island Corp
FLIC
| $724K | ﹤0.01% |
26,774
+814
| +3% | +$22.3K |
|
|
CUNB
2081
DELISTED
CU Bancorp
CUNB
| $724K | ﹤0.01% |
18,248
+637
| +4% | +$23.9K |
|
|
IMMU
2082
DELISTED
Immunomedics Inc
IMMU
| $719K | ﹤0.01% |
111,116
+4,107
| +4% | +$20.8K |
|
2083
Central Garden & Pet Co
CENT
$2.69B
| $717K | ﹤0.01% |
24,186
+7,677
| +47% | +$212K |
|
|
KBAL
2084
DELISTED
Kimball International
KBAL
| $715K | ﹤0.01% |
43,363
+1,390
| +3% | +$23.2K |
|
|
RPXC
2085
DELISTED
RPX Corporation
RPXC
| $714K | ﹤0.01% |
59,493
+1,541
| +3% | +$17.5K |
|
|
ACTA
2086
DELISTED
Actua Corp
ACTA
| $714K | ﹤0.01% |
50,792
+1,424
| +3% | +$20K |
|
2087
Axcelis
ACLS
$4.01B
| $712K | ﹤0.01% |
37,869
+1,132
| +3% | +$17.8K |
|
|
P
2088
Everpure Inc
P
$25.7B
| $711K | ﹤0.01% |
72,375
+2,545
| +4% | +$28.2K |
|
|
OPB
2089
DELISTED
Opus Bank Common Stock
OPB
| $711K | ﹤0.01% |
35,288
+9,866
| +39% | +$226K |
|
2090
Red Rock Resorts
RRR
$3.77B
| $710K | ﹤0.01% |
31,996
+1,223
| +4% | +$27.9K |
|
2091
Gorman-Rupp
GRC
$2.14B
| $709K | ﹤0.01% |
22,577
+92
| +0.4% | +$2.87K |
|
2092
LivePerson
LPSN
$21.8M
| $705K | ﹤0.01% |
6,860
+1,973
| +40% | +$211K |
|
|
UCTT
2093
Ultra Clean Holdings
UCTT
$3.73B
| $705K | ﹤0.01% |
41,769
+1,433
| +4% | +$19K |
|
2094
Usana Health Sciences
USNA
$408M
| $705K | ﹤0.01% |
12,246
+349
| +3% | +$20.8K |
|
|
GBT
2095
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $705K | ﹤0.01% |
19,131
+2,089
| +12% | +$52.6K |
|
|
CRC
2096
DELISTED
California Resources Corporation
CRC
| $703K | ﹤0.01% |
46,724
+5,179
| +12% | +$95.1K |
|
|
GTT
2097
DELISTED
GTT Communications, Inc.
GTT
| $703K | ﹤0.01% |
28,891
+840
| +3% | +$22.8K |
|
|
CTWS
2098
DELISTED
Connecticut Water Service Inc
CTWS
| $699K | ﹤0.01% |
13,158
+462
| +4% | +$25K |
|
2099
PDF Solutions
PDFS
$1.93B
| $697K | ﹤0.01% |
30,797
+926
| +3% | +$20.6K |
|
2100
Hyster-Yale Materials Handling
HY
$599M
| $695K | ﹤0.01% |
12,330
-679
| -5% | -$41.2K |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2017 Portfolio in Review
As of Q1 2017, RhumbLine Advisers held 2,894 positions worth $42.8B, up 8.5% from $39.5B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
RhumbLine Advisers deployed $1.35B of net new capital in Q1 2017, opening 39 new positions and adding to 2,631 existing holdings. Its largest new stake was Bioverativ Inc. Common Stock: 197,812 shares worth $10.8M.
By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Biogen, an estimated $8.21M trimmed.
- RhumbLine Advisers's largest Q1 2017 buy was Bioverativ Inc. Common Stock: 197,812 shares worth $10.8M.
- RhumbLine Advisers added most to Abbott in Q1 2017, an estimated $21.8M increase.
- RhumbLine Advisers's biggest Q1 2017 reduction was Biogen, cutting an estimated $8.21M.
- RhumbLine Advisers fully exited Spectra Energy Corp Wi in Q1 2017, selling an estimated $49.6M.
- RhumbLine Advisers's ten largest holdings make up 15% of its $42.8B portfolio in Q1 2017.
- RhumbLine Advisers opened 39 new positions and closed 44 in Q1 2017.
- RhumbLine Advisers's portfolio value rose 8.5% quarter-over-quarter to $42.8B.
Based on RhumbLine Advisers's 13F filing for Q1 2017, filed 2 May 2017.